(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

FERAHEME FERUMOXYTOL INJECTION

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

FERAHEME FERUMOXYTOL INJECTION

ST13

US500000085968862

Class

5

Filing

85968862

Registration

4509702

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

55

Latest update

06/05/2025

Trademark type

Combined

Nice classes

5

Filing date

06/25/2013

Registration date

04/08/2014

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/01/2024

Last transaction

06/05/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

07/14/2009

First use in commerce

07/14/2009

Drawing code

3

Owner type

16

Owner location

ZUG, CH

Examiner

HAYES, GINA

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the terms "FERAHEME", "FERUMOXYTOL", and "INJECTION" in stylized font, and an oval surrounded in part by another oval. The term "FERAHEME" is located above the term "FERUMOXYTOL", which in turn is located above the term "INJECTION". The ovals are located to the right of the terms "FERUMOXYTOL" and "INJECTION", and below the term "FERAHEME".

Holders and representatives

Holders

COVIS PHARMA GMBH
AMAG Pharmaceuticals, Inc.

Representatives

Laura K. Pitts Buchanan Ingersoll & Rooney PC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationsferumoxytol for the treatment of hematological diseases and conditions

Publications

History of USPTO decisions and trademark events.

55 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

06/04/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

04/01/2025

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

07/01/2024

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

07/01/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/01/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/01/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

04/02/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

04/08/2023

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

06/23/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/19/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

02/09/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/17/2021

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

02/17/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/17/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/17/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/17/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/11/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/11/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/11/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/11/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/11/2021

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

05/08/2020

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

05/08/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/08/2020

E815

TEAS SECTION 8 & 15 RECEIVED

03/16/2020

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

04/08/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/19/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

04/08/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/21/2014

PUBO

PUBLISHED FOR OPPOSITION

01/21/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/01/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

12/16/2013

ALIE

ASSIGNED TO LIE

12/12/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/10/2013

XAEC

EXAMINER'S AMENDMENT ENTERED

12/10/2013

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/10/2013

GNEA

EXAMINERS AMENDMENT E-MAILED

12/10/2013

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/10/2013

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/09/2013

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/09/2013

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

12/09/2013

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

11/17/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/05/2013

ALIE

ASSIGNED TO LIE

10/30/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/15/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/11/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/11/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/11/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/07/2013

GNRT

NON-FINAL ACTION E-MAILED

10/07/2013

CNRT

NON-FINAL ACTION WRITTEN

10/07/2013

DOCK

ASSIGNED TO EXAMINER

10/04/2013

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

07/09/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/06/2013

NWAP

NEW APPLICATION ENTERED

06/28/2013

Continuous trademark protection

Get notified about every new filing that threatens FERAHEME FERUMOXYTOL INJECTION or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.